Primary Menu

Stem cells work together to make hair grow

Your hair may seem unwilling to cooperate some mornings, but at the root of each strand is a tiny partnership of stem cells that work very well together to make hair happen. New research from The Rockefeller University has elucidated how these adult stem cells communicate with each other to make hair grow and give it pigment.

Adult stem cells are found throughout the body and, like embryonic stem cells, can self-renew indefinitely, forming new cells for the organ in which they reside and aiding in the repair of damaged tissue. In the hair follicle, stem cells come in two types: hair follicle stem cells, which help the hair to grow, and melanocyte stem cells, which give it color.

Fuchs’ research team knew that these two stem cell populations share a niche, a microenvironment that interacts with stem cells and influences their fate inside the hair follicles. In a paper published in Nature in February, they discovered a working relationship between the stem cells that allows hair to be pigmented.

Chang examined the role of nuclear factor I/B (NFIB), a transcription factor that controls gene expression in the hair follicle stem cells. The lab created so-called knockout mice whose hair follicle stem cells were missing the gene Nfib and watched to see what would happen. At first it seemed like not much — the hair on the mice grew like it normally would. But upon closer inspection, Chang found that surprisingly, the melanocyte stem cell behavior had gone awry. Even though the melanocyte stem cells weren’t directly affected by the NFIB knockout, the mice had more of these pigment-producing cells and the cells were differentiating faster than they did in the normal hair cycle. Over the course of many months the knockout mice also showed dark spots of pigment around the hair follicle, visible to the naked eye.

It seemed that NFIB acts as a mediator in the crosstalk between hair follicle stem cells and melanocytes — controlling the timing and number of melanocytes through the action of the hair follicle stem cells. The next question was how, exactly?

Through techniques known as ChIP-sequencing and transcriptional profiling the group determined that NFIB was working through a gene called endothelin-2, and showed that hair follicle stem cells that were missing NFIB had more endothelin-2 protein. NFIB appears to have an effect on the hair cycle, a process whereby the hair follicle goes from dormant to having its stem cells activated, making the hair grow. NFIB was found to limit the amount of endothelin-2 secreted while the niche is resting, keeping endothelin-2 from spurring the melanocyte stem cells to differentiate too early — before the hair starts to grow again.

“What we learned was that NFIB acts as a governor over this process of hair regeneration and pigmentation,” says Chang. “It keeps the hair follicle and melanocyte stem cells working in synchrony to maintain the process.”

“Before Chiung-Ying’s findings, researchers knew how stem cells became activated together, but they didn’t know how they remain silent for prolonged periods of time,” says Fuchs. “Also important is Chiung-Ying’s discovery of how the activities of the two stem cells can be uncoupled, since only melanocyte stem cells respond to endothelin-2.”

The scientists state that synchrony between the two types of cells can come unhinged in a number of stress or disease conditions. In future research they hope to address whether changes in Nfib expression may play an important signaling role in these conditions, noting that situations like UV exposure, where the synchrony is disrupted, are correlated with an increase in endothelin-2.

from http://newswire.rockefeller.edu/2013/02/06/in-sync-stem-cells-work-together-to-make-hair-grow-give-it-color/

Stem cells are basic cells that can become almost any type of cell in the body. Human stem cells can come from an embryo or an adult human. They have many possible uses in science and medicine, yet controversy surrounds them.

New research has identified rogue cells -- namely brain and muscle cells -- lurking within kidney organoids. Such cells make up only 10 to 20 percent of an organoid's cells, but their presence indicates that the 'recipes' used to coax stem cells into becoming kidney cells inadvertently are churning out other cell types.

A new study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Clinical trial based on this observation may revolutionize care for older adults with acute myeloid leukemia.

Researchers have developed a way to grow human heart tissue that can serve as a model for the upper chambers of the heart, known as the atria. The tissue, derived from human induced pluripotent stem cells (hiPCSs), beats, expresses genes, and responds to drugs in a manner similar to a real human atrium. The model […]

Scientists have created a tiny, biodegradable scaffold to transplant stem cells and deliver drugs, which may help treat Alzheimer's and Parkinson's diseases, aging brain degeneration, spinal cord injuries and traumatic brain injuries. Stem cell transplantation, which shows promise as a treatment for central nervous system diseases, has been hampered by low cell survival rates, incomplete […]

Promising findings from preclinical animal studies show the potential of gene therapy for treating incurable neurological disorders. Scientists have successfully used gene therapy to slow the progression and improve symptoms of disorders such as amyotrophic lateral sclerosis and Parkinson's disease.

A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia type 7 (SCA7) and validates a new form of therapy with the potential to treat neurogenetic diseases effectively and with […]